Akira Takeda
Docent
akitak@utu.fi +358 29 450 4383 Tykistökatu 6 Turku ORCID identifier: https://orcid.org/0000-0003-4748-4543 |
Areas of expertise
Immunology
Immunology
Publications
- Breast cancer remodels lymphatics in sentinel lymph nodes (2025)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment (2025)
- Journal for Immunotherapy of Cancer
(A1 Refereed original research article in a scientific journal) - Endothelial Adhesion Molecules in the Lymphatic Vasculature (2024) Encyclopedia of Immunobiology Takeda, Akira; Jalkanen, Sirpa; Salmi, Marko
(D2 Article in a professional compilation book) - Lymph node lymphatic endothelial cells as multifaceted gatekeepers in the immune system (2023)
- Trends in Immunology
(A2 Refereed review article in a scientific journal ) - Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop (2022)
- Cancer Cell
(A1 Refereed original research article in a scientific journal) - CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity (2022)
- Cellular and Molecular Life Sciences
(A1 Refereed original research article in a scientific journal) - Infection with the enteric pathogen C. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node (2022)
- Mucosal Immunology
(A1 Refereed original research article in a scientific journal) - CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice (2021)
- European Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1 (2021)
- Frontiers in immunology
(A1 Refereed original research article in a scientific journal) - Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial (2021)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal)



